Publications by authors named "Carsten Werner Lederer"

Claim this Profile
H
HELIOS Action: Advancing research, education, and equity in hemoglobinopathies across Europe and beyond.
Sotiroula Chatzimatthaiou, Fedele Bonifazi, Anna C Gimbert, Raffaella Colombatti, Francesco Cremonesi, Carsten Werner Lederer

Hemasphere· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proceedings of the second annual meeting of GenE-HumDi (COST Action 21113).
María Ortiz-Bueno, Iris Ramos-Hernández, Luis Algeciras-Jiménez, Nechama Kalter, Juan Roberto Rodríguez-Madoz, Carsten Werner Lederer

Front Genome Ed· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of ER Composition and Extent, and Putative Action in Protein Networks by ER/NE Protein TMEM147.
Giannis Maimaris, Andri Christodoulou, Niovi Santama, Carsten Werner Lederer

Int J Mol Sci· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Mutation-Specific Gene Editing for Blood Disorders.
Carsten Werner Lederer, Pietro Genovese, Annarita Miccio, Sjaak Philipsen

Front Genome Ed· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Scope for Thalassemia Gene Therapy by Disruption of Aberrant Regulatory Elements.
Petros Patsali, Claudio Mussolino, Petros Ladas, Argyro Floga, Annita Kolnagou, Carsten Werner Lederer

J Clin Med· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple Integrated Non-clinical Studies Predict the Safety of Lentivirus-Mediated Gene Therapy for β-Thalassemia.
Maria Rosa Lidonnici, Ylenia Paleari, Francesca Tiboni, Giacomo Mandelli, Claudia Rossi, Carsten Werner Lederer

Mol Ther Methods Clin Dev· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plerixafor+G-CSF-mobilized CD34+ cells represent an optimal graft source for thalassemia gene therapy.
Garyfalia Karponi, Nikoletta Psatha, Carsten Werner Lederer, Jennifer Eileen Adair, Fani Zervou

Blood· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone marrow as an alternative site for islet transplantation.
Elisa Cantarelli, Raffaella Melzi, Alessia Mercalli, Valeria Sordi, Giuliana Ferrari, Carsten Werner Lederer

Blood· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis